Sales of Roche’s Rituxan Have Started to Decline as Biosimilars Thereof are Marketed
Author: 1℃
Celltrion and Teva Pharmaceutical released big news on October 11, 2018 that the Rituxan? (rituximab) biosimilar. After the marketing, CT-P10 will become the first Rituxan? (rituximab) biosimilar approved for marketing in the U.S.
Read the full article:
Sales of Roche’s Rituxan Have Started to Decline as Biosimilars Thereof are Marketed
-----------------------------------------------------------------------
Editor's Note:
To apply for becoming a contributor of En-CPhI.cn,
welcome to send your CV and sample works to us,
Email: [email protected].